|1.||Yim, Dongsool: 2 articles (04/2005 - 04/2002)|
|2.||Wang, Xin: 1 article (01/2015)|
|3.||Liu, Youping: 1 article (01/2015)|
|4.||Feng, Xinchi: 1 article (01/2015)|
|5.||Di, Xin: 1 article (01/2015)|
|6.||Lee, Sun-Mee: 1 article (09/2014)|
|7.||Kwak, Jong-Hwan: 1 article (09/2014)|
|8.||Kim, Seok-Joo: 1 article (09/2014)|
|9.||Kim, Joon-Sung: 1 article (09/2014)|
|10.||Kim, Young Ho: 1 article (09/2014)|
|1.||Prostatic Neoplasms (Prostate Cancer)
04/01/2005 - "Acacetin inhibits cell growth and cell cycle progression, and induces apoptosis in human prostate cancer cells: structure-activity relationship with linarin and linarin acetate."
04/01/2005 - "This study was carried out to assess the anticancer efficacy of linarin (LN), linarin acetate (LA) and acacetin (AC), the flavonoid compounds with the same flavone ring structure but different substitution, against human prostate cancer (PCA), LNCaP and DU145 cells. "
|2.||Sleep Initiation and Maintenance Disorders (Insomnia)
|4.||Retinoblastoma (Glioblastoma, Retinal)
10/01/2013 - "To find out whether linarin can be used as a potential natural inhibitor to target CDK4 in retinoblastoma using virtual screening studies. "
10/01/2013 - "Virtual screening studies reveal linarin as a potential natural inhibitor targeting CDK4 in retinoblastoma."
10/01/2013 - "The docking results indicate linarin, a flavonoid plant compound, as a potential inhibitor of CDK4 compared to some of the currently practiced anticancer drugs for retinoblastoma. "